China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE:000999)

Market Cap	52.71B
Revenue (ttm)	27.62B
Net Income (ttm)	3.37B
Shares Out	1.28B
EPS (ttm)	2.63
PE Ratio	15.60
Forward PE	13.47
Dividend	2.00 (4.85%)
Ex-Dividend Date	Nov 29, 2024

Volume	13,230,973
Average Volume	10,439,254
Open	41.07
Previous Close	41.04
Day's Range	41.07 - 41.94
52-Week Range	36.24 - 52.55
Beta	0.41
RSI	44.90
Earnings Date	Mar 13, 2025

About SHE:000999

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injecti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 20,318
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2024, SHE:000999's revenue was 27.62 billion, an increase of 11.63% compared to the previous year's 24.74 billion. Earnings were 3.37 billion, an increase of 18.05%.